Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 902.80 billion. The enterprise value is 953.93 billion.

Market Cap	902.80B
Enterprise Value	953.93B

Important Dates

The next estimated earnings date is Friday, May 22, 2026.

Earnings Date	May 22, 2026
Ex-Dividend Date	Aug 8, 2025

Share Statistics

Current Share Class	412.81M
Shares Outstanding	n/a
Shares Change (YoY)	+2.76%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	57.71%
Owned by Institutions (%)	20.74%
Float	106.31M

Valuation Ratios

The trailing PE ratio is 50.74 and the forward PE ratio is 38.75.

PE Ratio	50.74
Forward PE	38.75
PS Ratio	6.49
PB Ratio	5.81
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	53.61
EV / Sales	6.86
EV / EBITDA	29.30
EV / EBIT	38.19
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.54
Debt / EBITDA	2.58
Debt / FCF	n/a
Interest Coverage	3.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	10.07%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.09M
Profits Per Employee	906,906
Employee Count	19,620
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Mankind Pharma has paid 3.81 billion in taxes.

Income Tax	3.81B
Effective Tax Rate	17.42%

Stock Price Statistics

The stock price has decreased by -4.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.46%
50-Day Moving Average	2,144.69
200-Day Moving Average	2,351.50
Relative Strength Index (RSI)	54.93
Average Volume (20 Days)	18,860

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 139.14 billion and earned 17.79 billion in profits. Earnings per share was 43.10.

Revenue	139.14B
Gross Profit	97.74B
Operating Income	24.87B
Pretax Income	21.89B
Net Income	17.79B
EBITDA	32.33B
EBIT	24.87B
Earnings Per Share (EPS)	43.10

Full Income Statement

Balance Sheet

The company has 34.99 billion in cash and 83.69 billion in debt, giving a net cash position of -48.70 billion.

Cash & Cash Equivalents	34.99B
Total Debt	83.69B
Net Cash	-48.70B
Net Cash Per Share	n/a
Equity (Book Value)	155.29B
Book Value Per Share	370.26
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.25%, with operating and profit margins of 17.87% and 12.79%.

Gross Margin	70.25%
Operating Margin	17.87%
Pretax Margin	15.73%
Profit Margin	12.79%
EBITDA Margin	23.24%
EBIT Margin	17.87%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.05%.

Dividend Per Share	1.00
Dividend Yield	0.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-2.76%
Shareholder Yield	-2.71%
Earnings Yield	1.97%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2